ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
7
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,378
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Oral PI3 kinase inhibitor BKM120 monotherapy in patients (pts) with advanced solid tumors: an update on safety and efficacy
Author(s):
B Graña
,
H.A. Burris
,
J. Rodon Ahnert
,
H Burris
,
J Rodon
Publication date:
2011
Journal:
J Clin Oncol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
3,378
Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
Authors:
U Matulonis
,
GM Wulf
,
MJ Birrer
Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120
Authors:
Davood Bashash
,
Mahda Delshad
,
Ava Safaroghli-Azar
…
Kami Maddocks OSUCCC. Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma
Authors:
See all similar
Cited by
2
Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors
Authors:
Yuichi Ando
,
Megumi Inada-Inoue
,
Ayako Mitsuma
…
Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition
Authors:
Anna Dewan
,
Sameer Gupta
,
Daniel Q Bach
…
See all cited by